HTA64 Characteristics of Cell and Gene Therapies Authorized By the Food and Drug Administration and the European Medicines Agency
Abstract
Authors
V Kamerikar P Dheer BL Bermudez V Shukla R. Rodriguez-Monguio M Fleming E. Seoane-Vazquez